Peter Casterella MD
American Board of Internal Medicine General Cardiology, Board of Nuclear Cardiology; Board-eligible - Interventional Cardiology
Dr. Casterella received his medical degree from Georgetown University in Washington, D.C. He completed his residency at Naval Medical Center Oakland, Calif. and his fellowship training at Naval Medical Center San Diego in general cardiology and at Scripps Clinic in interventional cardiology.
Dr. Casterella comes to The Polyclinic from Swedish Heart and Vascular Clinic. Since 2001, he has worked in various private practices, including Scripps Clinic, Intermountain Health Care Utah Heart Clinic, and Seattle Cardiology.
“My health care experiences related to sports injuries during college, as well as my relationship with my childhood pediatrician who I saw as a role model, have helped to shape and form my aspirations for a career in medicine.”
Dr. Casterella enjoys treating a broad range of conditions and diagnoses encountered as a general cardiologist, including:
- Coronary artery disease, including preventive management and catheter-based revascularization procedures
- Peripheral vascular disease evaluation and treatment
- Hypertrophic cardiomyopathy (an inherited disease of the myocardium) evaluation and treatment
- Genetic defects of the heart such as Patent Foramen Ovale (PFO) and Atrial Septal Defect (ASD) evaluation and treatment
Outside of work, Dr. Casterella enjoys spending time with his family and dog, exercising, hiking, reading, Sudoku puzzles, cooking, and supporting local sports teams.
“I enjoy working collaboratively with patients and other medical colleagues to ensure that patients under my care receive the best-possible treatment to improve their health. I view medical care as a partnership using shared decision-making to find the best approach for each individual patient."
Dr. Casterella has authored a wide range of articles in publications. Below is a selection of articles.
- Steinhubl SR, Talley DJ, Braden GA, Tcheng JE, Casterella PJ et al. Point-of-Care Measured Platelet Inhibition Correlates with a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study. Circulation 2001;103:2572-8.
- Casterella PJ, Kereiakes DJ, Steinhubl SR, Raymond RE, et al. The Platelet Function Dose-Response to Abciximab During Percutaneous Coronary Revascularization Is Variable. Cathet Cardiovasc Intervent 2001;54:497-504.
- Bhatt DL, Lee BI, Casterella PJ, et al. Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2003;41:20-25.
- Casterella PJ, Revenaugh JR, Burke JL, et al. Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors during Percutaneous Coronary Intervention. J Invasive Cardiol 2008;20:94-98.
- Casterella PJ, Tcheng JE. Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: Practical implications, new clinical data, and recommended guideline revisions. Am Heart J 2008;155:781-90
Swedish Medical Center
- Uniformed Services University of Health Sciences (1995-97)
- Naval Medical Center Portsmouth VA (1994-1997)
- Scripps Clinic Interventional Fellowship Training Director (1998-2001)
- Adjunct Associate Professor of Medicine University of Utah (2001-2008)
Dr. Casterella is active in the American College of Cardiology. He attends continuing medical education programs each year to support ongoing learning. He regularly attends grand rounds and other medical education activities.
Swedish Physician Leadership Award - 2017